Revealing new treatment possibilities

REVEAL 2 Logo RGB[1]

Local doctors are looking to recruit women who are infected with human papillomavirus (HPV) and have precancerous cervical cells for participation in a clinical study.

The REVEAL 2 clinical study will examine the use of an investigational study drug and a medical device as a potential, less invasive treatment option for precancerous cells on the cervix.

If you qualify, you may receive at no cost:

  • An investigational study drug for HPV or a placebo
  • Study-related care from a local doctor
  • Compensation for time and travel

You may be eligible if you:

  • are a woman aged 18 years or older
  • have confirmed precancerous cells of the cervix with human papillomavirus (HPV) types 16 and/or 18
  • are not breastfeeding
  • are willing to use contraception during the period from screening until 6 months after the last dose of the investigational study drug

*If you have any questions regarding this clinical study, please contact us at: